, Tracking Stock Market Picks
Enter Symbol:
Endo Pharmaceuticals Holdings Inc. (ENDP) [hlAlert]

down 15.55 %

Endo Pharmaceuticals Holdings Inc. (ENDP) rated Buy with price target $88 by Deutsche Bank

Posted on: Tuesday,  Sep 29, 2015  12:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) on 09/29/2015. Previously Deutsche Bank rated Buy Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP)
on 04/13/2015., when the stock price was $93.55. Since then, Endo Pharmaceuticals Holdings Inc. has lost 15.55% as of 12/09/2015's recent price of $79.00.
If you would have followed the previous Deutsche Bank's recommendation on ENDP, you would have lost 15.55% of your investment in 240 days.

Endo Pharmaceuticals Holdings Inc., through its wholly owned subsidiaries, Endo Pharmaceuticals Inc. and Endo Inc., is engaged in the research, development, sales and marketing of branded and generic prescription pharmaceuticals used primarily for the treatment and management of pain.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/29/2015 12:25 PM Buy
62.31 88.00
as of 8/27/2015
1 Week down  -5.67 %
1 Month down  -5.87 %
3 Months down  -7.08 %
1 YTD down  -15.55 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/13/2015 1:25 PM Buy
93.55 96.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy